Search

Your search keyword '"Mancinelli, Luca"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Mancinelli, Luca" Remove constraint Author: "Mancinelli, Luca"
29 results on '"Mancinelli, Luca"'

Search Results

1. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis

2. Disease‐Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

4. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

5. Excavation of a tunnel with conventional method in urbanized context – A case study from Line 15 South of Grand Paris Express.

6. Comparative effectiveness of autologous hematopoietic stem cell transplant vs Fingolimod, Natalizumab, and Ocrelizumab in highly active relapsing-remitting multiple sclerosis

10. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

11. Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31

12. Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

13. Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy.

14. Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis

15. The MEM project: experiences, challenges and outcomes of an international double master-level degree

16. Prognostic indicators in pediatric clinically isolated syndrome

20. Holmes-Like Tremor in Ataxia With Oculomotor Apraxia Type 2

22. Numerical stability analysis of submerged slopes subject to rapid sedimentation processes.

23. Methamphetamine abuse and "meth mouth" in Europe.

24. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

25. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

26. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

27. Teeth loss after teriflunomide treatment: Casual or causal? A short case series

28. Italian Alemtuzumab Study Group. No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study

29. Tetrahydrocannabinol/Cannabidiol Oromucosal Spray in Patients With Multiple Sclerosis: A Pilot Study on the Plasma Concentration-Effect Relationship

Catalog

Books, media, physical & digital resources